Get the Stockscreener App
14.49
1.26%
0.18
After Hours:
14.49
Embecta Corp stock is traded at $14.49, with a volume of 285.34K.
It is up +1.26% in the last 24 hours and up +48.01% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$14.31
Open:
$14.32
24h Volume:
285.34K
Relative Volume:
0.45
Market Cap:
$847.45M
Revenue:
$1.10B
Net Income/Loss:
$83.60M
P/E Ratio:
10.13
EPS:
1.43
Net Cash Flow:
$132.30M
1W Performance:
-0.07%
1M Performance:
+48.01%
6M Performance:
+15.00%
1Y Performance:
-11.86%
1-Day Range:
$14.11
$14.51
1-Week Range:
$14.08
$14.82
52-Week Range:
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
14.49 | 855.05M | 1.10B | 83.60M | 132.30M | 1.43 |
|
ISRG
Intuitive Surgical Inc
|
454.52 | 168.15B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
191.26 | 53.93B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.81 | 39.68B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.91 | 38.70B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
247.54 | 17.53B | 2.96B | 487.70M | 344.00M | 6.68 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
Embecta at Wells Fargo Conference: Strategic Growth After Spin-Off - Investing.com
Is Embecta Corp. stock showing strong momentum2025 Market Trends & Daily Volume Surge Signals - khodrobank.com
Applying big data sentiment scoring on Embecta Corp.Portfolio Growth Summary & Expert Approved Momentum Ideas - Newser
What institutional flow reveals about Embecta Corp.Quarterly Performance Summary & Target Return Focused Stock Picks - Newser
Using data filters to optimize entry into Embecta Corp.2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - Newser
News impact scoring models applied to Embecta Corp.July 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser
Is Embecta Corp. a candidate for recovery playSwing Trade & Risk Managed Investment Strategies - Newser
Is Embecta Corp. backed by strong institutional buying2025 Investor Takeaways & Low Volatility Stock Suggestions - khodrobank.com
Using RSI to spot recovery in Embecta Corp.July 2025 Trends & Safe Capital Growth Tips - Newser
What moving averages say about Embecta Corp.2025 Big Picture & Entry and Exit Point Strategies - Newser
Using R and stats models for Embecta Corp. forecastingJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
Is Embecta Corp. still worth holding after the dip2025 Top Gainers & High Accuracy Swing Trade Signals - Newser
Heatmap analysis for Embecta Corp. and competitorsMarket Weekly Review & Safe Capital Growth Trade Ideas - Newser
Should you hold or exit Embecta Corp. nowRate Hike & Weekly Watchlist of Top Performers - Newser
Embecta Corp. Inches Toward Key Resistance — Will It Break getLinesFromResByArray error: size == 0 - 강소기업뉴스
How to use a screener to detect Embecta Corp. breakoutsWeekly Trade Recap & Free High Return Stock Watch Alerts - Newser
How did Embecta's revenue and expenses trend in Q1 2025? - AInvest
Signal Recap: Does Embecta Corp. have high return on assetsWatch List & Low Drawdown Momentum Ideas - khodrobank.com
Is Embecta Corp. gaining market shareJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - khodrobank.com
What MACD signals say about Embecta Corp.Weekly Volume Report & Target Return Focused Picks - Newser
Is Embecta Corp. stock a buy or sellJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - khodrobank.com
Will Embecta Corp. stock hit new highs in YEARWeekly Market Report & Consistent Income Trade Recommendations - khodrobank.com
Applying big data sentiment scoring on Embecta CorpIndex Update & Safe Swing Trade Setup Alerts - Newser
Does Embecta Corp. have high return on assetsQuarterly Trade Summary & Real-Time Buy Zone Alerts - khodrobank.com
Insulin Delivery Device Company Evaluation Report 2025 | Embecta, Novo Nordisk, and Ypsomed Lead with Innovative Injection and Digital Management Solutions - uk.finance.yahoo.com
Embecta Corp. stock outlook for YEAREarnings Miss & Smart Allocation Stock Reports - Newser
Analyzing Embecta Corp. with risk reward ratio charts2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
What institutional flow reveals about Embecta CorpQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - Newser
Recovery Signals Appearing in Embecta Corp. Charts getLinesFromResByArray error: size == 0 - 강소기업뉴스
RSI Crosses Above 30 for Embecta Corp. — Reversal in Sight2025 Big Picture & AI Powered Market Entry Ideas - 선데이타임즈
Published on: 2025-08-31 22:45:11 - beatles.ru
Developing predictive dashboards with Embecta Corp. dataMarket Volume Summary & Weekly Momentum Stock Picks - Newser
Embecta Corp. recovery potential after sell offQuarterly Performance Summary & Scalable Portfolio Growth Ideas - Newser
Embecta Corp. Reports Record Revenue and Debt Reduction - MSN
Why Embecta's Strategic Reorganization and Expansion into GLP-1 Markets Signal a High-Conviction Buy Opportunity - AInvest
Upgrading Embecta Due To Reorganization And Growth Initiatives (NASDAQ:EMBC) - Seeking Alpha
Can swing trading help recover from Embecta Corp. lossesJuly 2025 Trends & Weekly Market Pulse Alerts - Newser
Embecta Corp. Ranks High in Smart Money Tracker getLinesFromResByArray error: size == 0 - 강소기업뉴스
Embecta Corp.’s Price Action Aligns with Quant Signals getLinesFromResByArray error: size == 0 - newsyoung.net
Can machine learning forecast Embecta Corp. recoveryPortfolio Gains Report & Fast Entry Momentum Trade Alerts - Newser
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Embecta Corp Stock (EMBC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
1.77%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):